Nicholas Stuart Wilson
38Patents
5h-index
47Co-inventors
61Inventor score
Filing activity: May 6, 2016 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11124582B2 | FLT3L-FC fusion proteins | Chemistry; Metallurgy | 16 | Active |
| US10259882B2 | Anti-OX40 antibodies | Physics | 11 | Active |
| US10639368B2 | Anti-TIM-3 antibodies and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US10836830B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US10626181B2 | Nucleic acids encoding anti-OX40 antibodies | Physics | 5 | Active |
| US10144779B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10912831B1 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10479833B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10577426B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10323091B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11013802B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10800849B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10882908B2 | Anti-LAG-3 antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10912828B2 | Anti-TIM-3 antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10844119B2 | Anti-LAG-3 antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10894834B2 | CD131 binding proteins | Physics | 1 | Active |
| US11345755B2 | Anti-PD-1 antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11021537B2 | Anti-TIGIT antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11638755B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11692042B2 | Anti-CD73 antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11267889B2 | Anti-CTLA-4 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12187795B2 | Anti-LAG-3 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11136404B2 | Anti-OX40 antibodies | Physics | 0 | Active |
| US11401335B2 | Anti-GITR antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11447557B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.